The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Endovascular Treatment Devices-Global Market Insights and Sales Trends 2024
Synopsis
Endovascular treatment includes procedure types such as EVAR and TEVAR. Aneurysm types include infrarenal, juxtarenal and thoracic.
The global Endovascular Treatment Devices market size is expected to reach US$ 2614.7 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Endovascular Treatment Devices in various end use industries. The expanding demands from the Hospital, Clinic and Other, are propelling Endovascular Treatment Devices market. Endovascular Aortic Repair(EVAR), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Thoracic Endovascular Aortic/Aneurysm Repair(TEVAR) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Endovascular Treatment Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Endovascular Treatment Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Endovascular Treatment Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Endovascular Treatment Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Endovascular Treatment Devices covered in this report include Boston Scientific Corp, Cardinal Health, Cook Group Inc, Getinge AB and Terumo Corp, etc.
The global Endovascular Treatment Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific Corp
Cardinal Health
Cook Group Inc
Getinge AB
Terumo Corp
Global Endovascular Treatment Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Endovascular Treatment Devices market, Segment by Type:
Endovascular Aortic Repair(EVAR)
Thoracic Endovascular Aortic/Aneurysm Repair(TEVAR)
Global Endovascular Treatment Devices market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Endovascular Treatment Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Endovascular Treatment Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Endovascular treatment includes procedure types such as EVAR and TEVAR. Aneurysm types include infrarenal, juxtarenal and thoracic.
The global Endovascular Treatment Devices market size is expected to reach US$ 2614.7 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Endovascular Treatment Devices in various end use industries. The expanding demands from the Hospital, Clinic and Other, are propelling Endovascular Treatment Devices market. Endovascular Aortic Repair(EVAR), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Thoracic Endovascular Aortic/Aneurysm Repair(TEVAR) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Endovascular Treatment Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Endovascular Treatment Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Endovascular Treatment Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Endovascular Treatment Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Endovascular Treatment Devices covered in this report include Boston Scientific Corp, Cardinal Health, Cook Group Inc, Getinge AB and Terumo Corp, etc.
The global Endovascular Treatment Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific Corp
Cardinal Health
Cook Group Inc
Getinge AB
Terumo Corp
Global Endovascular Treatment Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Endovascular Treatment Devices market, Segment by Type:
Endovascular Aortic Repair(EVAR)
Thoracic Endovascular Aortic/Aneurysm Repair(TEVAR)
Global Endovascular Treatment Devices market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Endovascular Treatment Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Endovascular Treatment Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Endovascular Treatment Devices Market Overview
1.1 Endovascular Treatment Devices Product Overview
1.2 Endovascular Treatment Devices Market Segment by Type
1.2.1 Endovascular Aortic Repair(EVAR)
1.2.2 Thoracic Endovascular Aortic/Aneurysm Repair(TEVAR)
1.3 Global Endovascular Treatment Devices Market Size by Type
1.3.1 Global Endovascular Treatment Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Endovascular Treatment Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Endovascular Treatment Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Endovascular Treatment Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Endovascular Treatment Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Endovascular Treatment Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Endovascular Treatment Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Endovascular Treatment Devices Sales Breakdown by Type (2018-2023)
2 Global Endovascular Treatment Devices Market Competition by Company
2.1 Global Top Players by Endovascular Treatment Devices Sales (2018-2023)
2.2 Global Top Players by Endovascular Treatment Devices Revenue (2018-2023)
2.3 Global Top Players by Endovascular Treatment Devices Price (2018-2023)
2.4 Global Top Manufacturers Endovascular Treatment Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Endovascular Treatment Devices Market Competitive Situation and Trends
2.5.1 Endovascular Treatment Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Endovascular Treatment Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Endovascular Treatment Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Endovascular Treatment Devices Market
2.8 Key Manufacturers Endovascular Treatment Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Endovascular Treatment Devices Status and Outlook by Region
3.1 Global Endovascular Treatment Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Endovascular Treatment Devices Historic Market Size by Region
3.2.1 Global Endovascular Treatment Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Endovascular Treatment Devices Sales in Value by Region (2018-2023)
3.2.3 Global Endovascular Treatment Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Endovascular Treatment Devices Forecasted Market Size by Region
3.3.1 Global Endovascular Treatment Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Endovascular Treatment Devices Sales in Value by Region (2024-2029)
3.3.3 Global Endovascular Treatment Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Endovascular Treatment Devices by Application
4.1 Endovascular Treatment Devices Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Endovascular Treatment Devices Market Size by Application
4.2.1 Global Endovascular Treatment Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Endovascular Treatment Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Endovascular Treatment Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Endovascular Treatment Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Endovascular Treatment Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Endovascular Treatment Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Endovascular Treatment Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Endovascular Treatment Devices Sales Breakdown by Application (2018-2023)
5 North America Endovascular Treatment Devices by Country
5.1 North America Endovascular Treatment Devices Historic Market Size by Country
5.1.1 North America Endovascular Treatment Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Endovascular Treatment Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Endovascular Treatment Devices Sales in Value by Country (2018-2023)
5.2 North America Endovascular Treatment Devices Forecasted Market Size by Country
5.2.1 North America Endovascular Treatment Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Endovascular Treatment Devices Sales in Value by Country (2024-2029)
6 Europe Endovascular Treatment Devices by Country
6.1 Europe Endovascular Treatment Devices Historic Market Size by Country
6.1.1 Europe Endovascular Treatment Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Endovascular Treatment Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Endovascular Treatment Devices Sales in Value by Country (2018-2023)
6.2 Europe Endovascular Treatment Devices Forecasted Market Size by Country
6.2.1 Europe Endovascular Treatment Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Endovascular Treatment Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Endovascular Treatment Devices by Region
7.1 Asia-Pacific Endovascular Treatment Devices Historic Market Size by Region
7.1.1 Asia-Pacific Endovascular Treatment Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Endovascular Treatment Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Endovascular Treatment Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Endovascular Treatment Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Endovascular Treatment Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Endovascular Treatment Devices Sales in Value by Region (2024-2029)
8 Latin America Endovascular Treatment Devices by Country
8.1 Latin America Endovascular Treatment Devices Historic Market Size by Country
8.1.1 Latin America Endovascular Treatment Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Endovascular Treatment Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Endovascular Treatment Devices Sales in Value by Country (2018-2023)
8.2 Latin America Endovascular Treatment Devices Forecasted Market Size by Country
8.2.1 Latin America Endovascular Treatment Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Endovascular Treatment Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Endovascular Treatment Devices by Country
9.1 Middle East and Africa Endovascular Treatment Devices Historic Market Size by Country
9.1.1 Middle East and Africa Endovascular Treatment Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Endovascular Treatment Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Endovascular Treatment Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Endovascular Treatment Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Endovascular Treatment Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Endovascular Treatment Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Boston Scientific Corp
10.1.1 Boston Scientific Corp Company Information
10.1.2 Boston Scientific Corp Introduction and Business Overview
10.1.3 Boston Scientific Corp Endovascular Treatment Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Boston Scientific Corp Endovascular Treatment Devices Products Offered
10.1.5 Boston Scientific Corp Recent Development
10.2 Cardinal Health
10.2.1 Cardinal Health Company Information
10.2.2 Cardinal Health Introduction and Business Overview
10.2.3 Cardinal Health Endovascular Treatment Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Cardinal Health Endovascular Treatment Devices Products Offered
10.2.5 Cardinal Health Recent Development
10.3 Cook Group Inc
10.3.1 Cook Group Inc Company Information
10.3.2 Cook Group Inc Introduction and Business Overview
10.3.3 Cook Group Inc Endovascular Treatment Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Cook Group Inc Endovascular Treatment Devices Products Offered
10.3.5 Cook Group Inc Recent Development
10.4 Getinge AB
10.4.1 Getinge AB Company Information
10.4.2 Getinge AB Introduction and Business Overview
10.4.3 Getinge AB Endovascular Treatment Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Getinge AB Endovascular Treatment Devices Products Offered
10.4.5 Getinge AB Recent Development
10.5 Terumo Corp
10.5.1 Terumo Corp Company Information
10.5.2 Terumo Corp Introduction and Business Overview
10.5.3 Terumo Corp Endovascular Treatment Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Terumo Corp Endovascular Treatment Devices Products Offered
10.5.5 Terumo Corp Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Endovascular Treatment Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Endovascular Treatment Devices Industrial Chain Analysis
11.4 Endovascular Treatment Devices Market Dynamics
11.4.1 Endovascular Treatment Devices Industry Trends
11.4.2 Endovascular Treatment Devices Market Drivers
11.4.3 Endovascular Treatment Devices Market Challenges
11.4.4 Endovascular Treatment Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Endovascular Treatment Devices Distributors
12.3 Endovascular Treatment Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
